by Tel-Aviv University α-synuclein spread in the mouse brain. Credit: Tel Aviv University. Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson’s disease, which in the future may serve as a target for developing new treatments for this terrible ailment, affecting close to 10 million people worldwide. The researchers say,...
Tag: <span>Drug treatment for Parkinson’s disease</span>
Post
150-year-old drug may provide ‘off’ time relief for people with advanced Parkinson’s disease
Immunohistochemistry for alpha-synuclein showing positive staining (brown) of an intraneural Lewy-body in the Substantia nigra in Parkinson’s disease. New research provides evidence that an old drug may provide relief for people with advanced Parkinson’s, according to a study released today that will be presented at the American Academy of Neurology’s 69th Annual Meeting in...